Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis
Clinical trial NCT04399538 · COMPLETED
Trial details
- NCT number
- NCT04399538
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2022-03-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.